Additional Details
-
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
University of California, Los Angeles (Site #: 71123)Los Angeles CA. 90095View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Cleveland Clinic (Site #: 71101)Cleveland OH. 44195View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Johns Hopkins (Site #: 71119)Baltimore MD. 21287View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Duke University (Site #: 71139)Durham NC. 27710View Details -
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
The University of Texas Health Science Center at HoustonHouston TX. 77030View Details -
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
MD Anderson Cancer CenterHouston TX. 77030View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of California San FranciscoSan Francisco CA. 94143View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of MichiganAnn Arbor MI. 48109View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of KansasKansas City KS. 66103View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of Colorado DenverAurora CO. 80045View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Banner Health - University Medical Center PhoenixPhoenix AZ. 85006View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
UT Southwest Medical Center Heart and Lung ClinicDallas TX. 75390View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of North Carolina at Chapel HillChapel Hill NC. 27514View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Washington University School of MedicineSt Louis MO. 63110View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of Utah HealthSalt Lake City UT. 84108View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
The Cleveland ClinicCleveland OH. 44195View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Virginia Commonwealth UniversityRichmond VA. 23298View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
New York Presbyterian Hospital - Weill Cornell MedicineNew York NY. 10021View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of Wisconsin Hospital and ClinicsMadison WI. 53792View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Loyola University Medical CenterMaywood IL. 60153View Details